In a letter to Senate Health, Education, Labor & Pensions (HELP) Committee leadership, ACCC and 71 other patient advocacy organizations urge the Committee to include House-passed clinical trials diversity provisions in the Senate version of the Prescription Drug User Fee Act (PDUFA) reauthorization package.
